Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multi-center, Randomized Controlled Study of Neuromuscular Blocking Effect and Safety of Mivacurium Chloride in Pediatric Patients

NCT02117401 is registered in ClinicalTrials.gov with Jiangsu Nhwa Pharmaceutical Co., Ltd. as lead sponsor.

NCT NCT02117401
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02117401 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multi-center, Randomized Controlled Study of Neuromuscular Blocking Effect and Safety of Mivacurium Chloride in Pediatric Patients
Lead sponsor
Jiangsu Nhwa Pharmaceutical Co., Ltd.
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2012
Completion date
June 30, 2013
Enrollment
1,152 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

efficacy and safety of mivacurium chloride for pediatric patients